Leading health tech company is the first to introduce novel approach to addressing the COVID-19 pandemic Read More »

The American Pharmacists Association (APhA) recommends that patients and/or caregivers ensure that they have adequate supplies of necessary medications to address their needs if not able to get to the pharmacy because of coronavirus. Read More »

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Brigham and Women's Hospital for an investigator-initiated study led by Richard D. Urman MD, MBA, Associate Professor of Anesthesia and co-director of the Center for Perioperative Research at Brigham and Women's Hospital and Harvard Medical School. Read More »

The American Pharmacists Association (APhA) submitted comments to the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) Antitrust Division addressing the impact vertical mergers are having on the pharmacy supply chain, medication pricing and patient access and choice. Read More »

FDA-approved GLOPERBA (colchicine) is now available in pharmacies Read More »

The educational sessions are available live and via simulcast Read More »

Healthcare Technology Company Becomes Organization’s Provider of Enterprise Solutions for Pharmacy Benefits Administration Read More »

As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx. Read More »

MakoRx's new disruptive pharmacy subscription model provides access to over 300 medications for free Read More »

Best in Class Ingredients from Diamond Dust to Caviar, Retinol to The Most Bioavailable Oil-Soluble Vitamin C Read More »

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that Anthem Biosciences of Bangalore, India (Anthem) has completed a pilot run of the recrystallization of the Reata Pharmaceuticals, Inc. API (Reata). Read More »

PharmaMar and Jazz signed an exclusive license agreement on 19 December 2019 for lurbinectedin in the United States Read More »

DisposeRx, Inc., manufacturer of the market leading at-home medication disposal solution, has in place a network of more than 1,000 pharmacies in New Jersey ready to meet the requirements of new legislation signed into law today. Read More »

Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today they are working with UF Health Jacksonville to help advance specialty pharmacy services. Read More »

Partnership designed to make essential compounded sterile products for CADD® infusion pumps more widely available Read More »

Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a new chemical drug for the treatment of major depressive disorder. It is also the second U.S. FDA NDA submission in the central nervous system (CNS) filed by the company. Read More »

In response to the announcement of Trump administration proposals to allow importation of certain prescription drugs, the American Pharmacists Association (APhA) expressed its overwhelming concerns for patient safety. Read More »

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced that it has completed its open label trial evaluating 8 mg twice-daily compared to 16 mg once-daily dosing of CTP-543 in patients with moderate-to-severe alopecia areata. Read More »

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). Read More »

e5 Pharma, LLC., today announced the U.S. launch of Diazoxide, USP Oral Suspension, the first generic version of the reference listed drug, Proglycem®. e5 Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) using the Competitive Generic Therapy (CGT) Pathway. Read More »